Results 31 to 40 of about 10,137 (203)
Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes
Frontiers in Cardiovascular Medicine, 2021 Immunomodulatory approaches are defined as all interventions that modulate and curb the immune response of the host rather than targeting the disease itself with the aim of disease prevention or treatment.
Lama A. Ammar +12 more
doaj +1 more source
Biomarkers in Cardiorenal Syndromes [PDF]
BioMed Research International, 2018 There is a consensus that cardiorenal syndromes (CRS) are defined as the disorders of heart and kidney where acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in another. Patients with CRS have increased hospitalization and mortality rates, and thus their identification is of great implication.
Shihui Fu +3 more
openaire +2 more sources
Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome. [PDF]
PLoS ONE, 2017 Intracellular accumulation of protein-bound uremic toxins in the setting of cardiorenal syndrome leads to adverse effects on cardiorenal cellular functions, where cardiac hypertrophy and cardiorenal fibrosis are the hallmarks. In this study, we sought to
Feby Savira +12 more
doaj +1 more source
Anemia of cardiorenal syndrome [PDF]
Kidney International Supplements, 2021 Cardiorenal syndrome includes a spectrum of disorders of the kidneys and heart in which loss of function in one organ contributes to reduced function in the other organ. Cardiorenal syndrome is frequently complicated by comorbid anemia, which leads to reciprocal and progressive cardiac and renal deterioration. The triad of heart failure, chronic kidney
openaire +2 more sources
Psychosocial stress and quality of life in patients with type 2 cardiorenal syndrome [PDF]
Archives of the Balkan Medical Union, 2019 Introduction. Multiple studies have assessed the role of the stress, as well as of the quality of life, in patients with heart failure. However, specific data about the quality of life in patients with cardiorenal syndrome (CRS) are limited.
Elena BIVOL, Livi GRIB
doaj +1 more source
New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy [PDF]
, 2023 Cardiorenal syndrome consists in the coexistence of acute or chronic dysfunction of heart and kidneys resulting in a cascade of feedback mechanisms and causing damage to both organs associated with high morbidity and mortality.
Giovanna Gallo +2 more
core +1 more source
BMC Cardiovascular Disorders, 2018 Background Severe aortic stenosis (AS) may lead to acute decompensated heart failure resistant to medical treatment. Here, we report a successful emergent transcatheter aortic valve replacement (TAVR) in a patient presenting with decompensated severe AS ...
Hongju Kim, Jung-Hee Lee
doaj +1 more source
, 2021 Aims This study investigated the renal protective effects and mechanisms of angiotensin receptor-neprilysin inhibitor LCZ696 in mice with cardiorenal syndrome.
Ying Li +11 more
core +1 more source
Cardiorenal syndrome: Mechanisms, risk and treatment
, 2010 Accelerated cardiovascular disease is a frequent complication of chronic kidney disease. Individuals with evidence of renal functional impairment are more likely to die of cardiovascular events than to progress to end stage renal disease.
Berbari A.E., Mancia G.
core +1 more source
Journal of International Medical Research, 2023 Streptococcal infection is a common cause of acute glomerulonephritis. Cardiac damage associated with streptococcal infection commonly occurs in acute rheumatic fever.
Shihui Hou +3 more
doaj +1 more source